Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
Neuromyelitis optica: atypical clinical and neuroradiological presentation.
Optical Coherence Tomography for the Radiologist.
Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses.
Month of birth and risk of multiple sclerosis in a Portuguese population.
Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
Pharmacogenomics of interferon-β in multiple sclerosis: What has been accomplished and how can we ensure future progress?
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Torque teno mini virus infection and multiple sclerosis.

Pages